Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mizuta

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Vox Sanguinis|March 11, 2015
Evaluation of the potassium adsorption capacity of a potassium adsorption filter during rapid blood transfusionH Matsuura, Y Akatsuka, C Muramatsu, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|July 5, 2001
[Intestinal permeability in Crohn's disease and effects of elemental dietary therapy]M Iwata, H Nakano, Y Matsuura, et al.
Bone Marrow Transplantation|September 20, 2016
High-dose cytarabine added to CY/TBI improves the prognosis of cord blood transplantation for acute lymphoblastic leukemia in adults: a retrospective cohort studyY Arai, T Kondo, A Shigematsu, et al.
Bone Marrow Transplantation|September 22, 2015
Impact of MRD and TKI on allogeneic hematopoietic cell transplantation for Ph+ALL: a study from the adult ALL WG of the JSHCTS Nishiwaki, K Imai, S Mizuta, et al.
Bone Marrow Transplantation|October 6, 2015
Influence of melphalan plus fludarabine-conditioning regimen in elderly patients aged ⩾55 years with hematological malignanciesK Miyao, M Sawa, Y Kuwatsuka, et al.
Leukemia|October 15, 2010
Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemiaS Mizuta, K Matsuo, F Yagasaki, et al.
Bone Marrow Transplantation|September 24, 2013
Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell TransplantationH Kanamori, S Mizuta, S Kako, et al.
Bone Marrow Transplantation|October 2, 2003
Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantationM Yanada, K Yamamoto, N Emi, et al.
Blood Cancer Journal|July 26, 2012
Prognostic factors influencing clinical outcome of allogeneic hematopoietic stem cell transplantation following imatinib-based therapy in BCR-ABL-positive ALLS Mizuta, K Matsuo, T Maeda, et al.
Bone Marrow Transplantation|June 13, 2017
GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemiaS Terakura, Y Kuwatsuka, S Yamasaki, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Vox Sanguinis|March 11, 2015
Evaluation of the potassium adsorption capacity of a potassium adsorption filter during rapid blood transfusionH Matsuura, Y Akatsuka, C Muramatsu, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|July 5, 2001
[Intestinal permeability in Crohn's disease and effects of elemental dietary therapy]M Iwata, H Nakano, Y Matsuura, et al.
Bone Marrow Transplantation|September 20, 2016
High-dose cytarabine added to CY/TBI improves the prognosis of cord blood transplantation for acute lymphoblastic leukemia in adults: a retrospective cohort studyY Arai, T Kondo, A Shigematsu, et al.
Bone Marrow Transplantation|September 22, 2015
Impact of MRD and TKI on allogeneic hematopoietic cell transplantation for Ph+ALL: a study from the adult ALL WG of the JSHCTS Nishiwaki, K Imai, S Mizuta, et al.
Bone Marrow Transplantation|October 6, 2015
Influence of melphalan plus fludarabine-conditioning regimen in elderly patients aged ⩾55 years with hematological malignanciesK Miyao, M Sawa, Y Kuwatsuka, et al.
Leukemia|October 15, 2010
Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemiaS Mizuta, K Matsuo, F Yagasaki, et al.
Bone Marrow Transplantation|September 24, 2013
Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell TransplantationH Kanamori, S Mizuta, S Kako, et al.
Bone Marrow Transplantation|October 2, 2003
Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantationM Yanada, K Yamamoto, N Emi, et al.
Blood Cancer Journal|July 26, 2012
Prognostic factors influencing clinical outcome of allogeneic hematopoietic stem cell transplantation following imatinib-based therapy in BCR-ABL-positive ALLS Mizuta, K Matsuo, T Maeda, et al.
Bone Marrow Transplantation|June 13, 2017
GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemiaS Terakura, Y Kuwatsuka, S Yamasaki, et al.
Pageof 4